Wikidata

(Q42515208)

English

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

scientific article

In more languages

Statements

title
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17610993
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17610993%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42515208&oldid=1672464755"